JFrog Artifactory Incorrect Authorization Vulnerability

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

• cpe jfrog/artifactoryversion unspecified
• vendor JFrog Artifactoryversion unspecified

How to fix CVE-2026-42016

• Recommended remediation

  Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines. CISA due date Sep 25, 2026.

• Official advisories

  • CISA KEV · cisa.gov
  • CVE.org · cve.org
  • FIRST EPSS · first.org
  • NIST NVD · nvd.nist.gov
  • VulnCheck KEV · vulncheck.com

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

1. Jul 27, 2026 · Catalog

   Detected

   JFrog Artifactory contains an incorrect authorization vulnerability that leads to a privilege escalation attack due to a validation check of the token signature/issuer and not the token’s scope.

2. Sep 11, 2026 · CISA KEV

   Known exploited

   Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating

3. Sep 11, 2026 · Catalog

   Updated

   JFrog Artifactory contains an incorrect authorization vulnerability that leads to a privilege escalation attack due to a validation check of the token signature/issuer and not the token’s scope.

4. Sep 25, 2026 · CISA KEV

   Remediation due

   Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating

Sources

• CISA KEVConfirmed exploitationCVE-2026-42016

  JFrog Artifactory contains an incorrect authorization vulnerability that leads to a privilege escalation attack due to a validation check of the token signature/issuer and not the token’s scope.

  cisa.gov
• CVE.orgVulnerability recordCVE-2026-42016

  Official CVE identifier

  cve.org
• FIRST EPSSExploitation probabilityCVE-2026-42016

  30-day exploitation probability 8.6%

  first.org
• NIST NVDVulnerability recordCVE-2026-42016

  JFrog Artifactory (Self Hosted) versions before 7.133.11 are vulnerable to a privilege escalation attack due to a validation check of the token signature/issuer and not the token’s scope.

  nvd.nist.gov
• VulnCheck KEVConfirmed exploitationCVE-2026-42016

  JFrog Artifactory contains an incorrect authorization vulnerability that leads to a privilege escalation attack due to a validation check of the token signature/issuer and not the token’s scope.

  vulncheck.com

References

• CISA note · docs.jfrog.com
• CISA note · docs.jfrog.com
• CISA note · nvd.nist.gov
• US Government Resource · cisa.gov
• CISA note · cisa.gov
• CISA note · cisa.gov
• VulnCheck exploitation evidence · cisa.gov
• Third Party Advisory · wiz.io

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.